Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Find out which is better for you: cash back or reward points. Make smart financial choices that suit your lifestyle today!
27,078 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
As volatility rises and headlines loom, investors ask: is the S&P 500 headed correction? This guide breaks down what ...
Today’s session showed a rally fade for Plug Power and a broader pullback in hydrogen names. This article breaks down...
When a single stock surges on earnings guidance, it signals more than a momentary spike. This guide explains why band...
Regencell Bioscience sits in the high-risk, high-reward world of early-stage biotech. Before you consider investing, ...
Solesence kicked off 2026 with a solid Q1 showing across core segments. This deep dive breaks down the numbers, what ...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
Southwest Airlines CEO Bob Jordan is taking a bold step to reclaim time for real work by blocking Wednesday through F...
Roblox faces a tough year in the market, but a rebound isn’t off the table. This guide breaks down the business, risk...
ServiceNow has faced a brutal market sell-off in 2026. This guide breaks down whether the decline creates a compellin...
UniFirst stock rocketing higher again today follows news of a blockbuster offer from Cintas. This article breaks down...
Garmin stock soared this week after the GPS giant posted a solid Q4 and guided higher for 2026. This article breaks d...